Pharma: Other News To Note

• Mylan Inc., of Pittsburgh, reported that its subsidiary Mylan Pharmaceuticals Inc. received FDA approval for its generic version of Janssen Pharmaceutical Inc.'s Sporanox (itraconazole), indicated for the treatment of fungal infections that begin in the lungs in patients who are intolerant of or refractory to amphotericin B therapy.